The Securities and Exchange Commission is launching an investigation into just how much Apple knew about the illness of company head Steve Jobs, and how much it disclosed, including whether it misled investors, according to Bloomberg.
Jobs has recently returned to work after a five-month absence, during which he underwent a liver transplant. Back in January he said he was taking leave to treat what he described as a “hormonal imbalance” but would continue as CEO. Just nine days after that things changed, as Jobs said his health situation was "more complex than I originally thought."
Apple COO Tim Cook would handle the company’s day-to-day running, but Jobs would remain CEO and "I plan to remain involved in major strategic decisions while I am out. Our board of directors fully supports this plan."
Although Jobs is often seen as crucial to Apple, profits still rose 15% during his absence.